Histone Deacetylase Inhibitors Antagonize Distinct Pathways to Suppress Tumorigenesis of Embryonal Rhabdomyosarcoma

Open Access

Peer-reviewed

Research Article

Terra Vleeshouwer-Neumann,

Affiliation Department of Pathology, University of Washington, Seattle, Washington, United States of America
⨯
Michael Phelps,

Affiliation Department of Pathology, University of Washington, Seattle, Washington, United States of America
⨯
Theo K. Bammler,

Affiliation Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, Washington, United States of America
⨯
James W. MacDonald,

Affiliation Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, Washington, United States of America
⨯
Isaac Jenkins,

Affiliation Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
⨯
Eleanor Y. Chen

* E-mail: eleanor2@uw.edu

Affiliation Department of Pathology, University of Washington, Seattle, Washington, United States of America
⨯

Reader Comments (0)

Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Cell differentiation
Is the Subject Area "Cell differentiation" applicable to this article?

Thanks for your feedback.
Differentiated tumors
Is the Subject Area "Differentiated tumors" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.
Chromatin immunoprecipitation
Is the Subject Area "Chromatin immunoprecipitation" applicable to this article?

Thanks for your feedback.
Histones
Is the Subject Area "Histones" applicable to this article?

Thanks for your feedback.
Carcinogenesis
Is the Subject Area "Carcinogenesis" applicable to this article?

Thanks for your feedback.